MetLife, Inc. (MET)
NYSE · New York, New York, USA · Founded 1868 · CEO Michel Khalaf
Valuation summary
$294.61 fair value versus $97.60 in the market, a difference of +201.8%. Rated Strong Buy.
| Fair value per share | $294.61 |
| Current share price | $97.60 |
| Upside / downside | +201.8% |
| Bear case | $184.38 |
| Bull case | $454.73 |
| Discount rate (WACC) | 9.9% |
| Terminal growth | 2.40% |
| Market capitalisation | $62B |
| EV / Sales | 0.8x |
About MetLife, Inc.
Founded in 1868. Michel Khalaf has been CEO since 2019. MetLife is one of the largest US life insurers, selling group benefits through employers — life, dental, disability — plus retirement solutions and international operations concentrated in Asia and Latin America. Group benefits is genuinely attractive: employers renew annually and switching disrupts every employee.
Investment case
- Group benefits has high retention and low capital intensity relative to individual life.
- Higher interest rates improve investment income on a very large asset base.
- Asian operations provide growth that US-only insurers lack.
Key risks
- Life insurance liabilities extend for decades, making the balance sheet hard to assess externally.
- Sensitive to credit losses in a large corporate bond portfolio.
- Long-term care and legacy blocks carry reserve risk.
Recent developments
- 2026-08-05 · Q2 2026 adjusted EPS rose 20% to $2.43 and adjusted ROE reached 17.0%; net investment income up 18% to $6.7 billion source
- 2026-08-05 · MetLife authorised a new $3 billion share repurchase, on top of about $400 million left under the April 2025 programme source
Revenue by segment
| Group Benefits | 35% |
| Retirement & Income | 27% |
| Asia | 20% |
| Latin America & Other | 18% |
Five-year forecast
| Revenue | Free cash flow | |
|---|---|---|
| Year 1 | $93.7B | $7.5B |
| Year 2 | $106.0B | $9.1B |
| Year 3 | $118.5B | $10.8B |
| Year 4 | $130.8B | $12.6B |
| Year 5 | $142.6B | $14.4B |
What the street says
A stable, capital-return-focused holding. Second-quarter 2026 adjusted EPS rose 20% to $2.43 with adjusted ROE of 17.0%, and a new $3 billion buyback authorisation in August 2026 reinforced the capital-return case. Interest rates and credit quality still drive most of the variance.
Comparable companies: ALL · MFC · MS · AFL · AXP · PGR · CB · AJG
Open the interactive model, price chart and sensitivity grid →